Accueil › Maladies pulmonaires interstitielles › Kansas › Kansas City
Essais cliniques pour Maladies pulmonaires interstitielles à Kansas City, KS
13 études pour Maladies pulmonaires interstitielles recherchent des participants dans et autour de Kansas City (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Recrutement en coursPhase 3
- University of Kansas Medical Center, Kansas City
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Recrutement en coursPhase 3
- University of Kansas Medical Center, Kansas City
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Recrutement en coursPhase 3
- USA002, Kansas City
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Recrutement en coursPhase 2
- University of Kansas Medical Center, Kansas City
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Recrutement en coursPhase 2
- Clinical Research Site, Kansas City
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Recrutement en coursÉtude observationnelle
- University of Kansas Medical Center, Kansas City
Platform Clinical Study for Conquering Scleroderma
Recrutement en coursPhase 2
- University of Kansas School of Medicine, Kansas City
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Recrutement en coursPhase 2/3
- University of Kansas Medical Center, Kansas City
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Recrutement en coursPhase 2
- The University of Kansas Medical Center Research Institute, Kansas City
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Recrutement en coursPhase 3
- University of Kansas Medical Center, Kansas City
Interstitial Lung Disease Research Unit Biobank
Recrutement en coursÉtude observationnelle
- The University of Kansas Medical Center, Kansas City
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
Recrutement en coursPhase 1Volontaires sains bienvenus
- University of Kansas Medical Center, Kansas City
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
Recrutement en coursÉtude observationnelle
- University of Kansas, Kansas City
Essais pour Maladies pulmonaires interstitielles dans d'autres villes
- New York City, NY18 études
- Philadelphia, PA16 études
- Los Angeles, CA14 études
- Charleston, SC13 études
- Durham, NC13 études
- Chicago, IL12 études
- Houston, TX12 études
- Aurora, CO11 études
- Ann Arbor, MI11 études
- Salt Lake City, UT9 études
- Dallas, TX9 études
- Boston, MA9 études
Autres études à Kansas City
- Maladie cardiovasculaire14 études
- Insuffisance cardiaque13 études
- Obésité13 études
- Mucoviscidose13 études
- Cancer du sein12 études
- Cancer de la vessie12 études
- Leucémie aiguë myéloïde12 études
- Cancer de la prostate12 études
- Cancer du poumon non à petites cellules11 études
- Cancer du poumon11 études
- BPCO9 études
- Asthme8 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.